Omeros Corporation
OMER
#5623
Rank
โ‚ฌ1.25 B
Marketcap
17,29ย โ‚ฌ
Share price
1.46%
Change (1 day)
355.45%
Change (1 year)

Earnings for Omeros Corporation (OMER)

Earnings in 2026 (TTM): โ‚ฌ14.66 Million

According to Omeros Corporation's latest financial reports the company's current earnings are โ‚ฌ38.42 Million. In 2025 the company made an earning of -โ‚ฌ0.11 Billion, an increase over its 2024 earnings that were of -โ‚ฌ0.15 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Omeros Corporation from 2009 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚ฌ14.66 M-114.28%
2025 -โ‚ฌ0.11 Billion-27.03%
2024 -โ‚ฌ0.15 Billion9.63%
2023 -โ‚ฌ0.13 Billion-9.57%
2022 -โ‚ฌ0.15 Billion-30.65%
2021 -โ‚ฌ0.21 Billion86.28%
2020 -โ‚ฌ0.11 Billion99.45%
2019 -โ‚ฌ55.1 Million-49.91%
2018 -โ‚ฌ0.11 Billion190.77%
2017 -โ‚ฌ37.83 Million-27.96%
2016 -โ‚ฌ52.51 Million-17.61%
2015 -โ‚ฌ63.74 Million1.88%
2014 -โ‚ฌ62.56 Million87.56%
2013 -โ‚ฌ33.36 Million
2011 -โ‚ฌ24.43 Million-8.96%
2010 -โ‚ฌ26.83 Million45.03%
2009 -โ‚ฌ18.5 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ23.35 B 163,925.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ6.15 B 43,128.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Genetic Technologies
GENE
-โ‚ฌ3.45 Million-124.19%๐Ÿ‡ฆ๐Ÿ‡บ Australia
Eterna Therapeutics
ERNA
-โ‚ฌ14.73 Million-203.39%๐Ÿ‡บ๐Ÿ‡ธ USA